# A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

> **NCT04135508** · PHASE3 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 554 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** BAT1406
- **DRUG:** Humira

## Key facts

- **NCT ID:** NCT04135508
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-13
- **Primary completion:** 2018-03-22
- **Final completion:** 2018-05-31
- **Target enrollment:** 554 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135508, "A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04135508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*